Roshawn A. Blunt - 11 Nov 2021 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Director
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
11 Nov 2021
Net transactions value
$0
Form type
4
Filing time
15 Nov 2021, 12:45:25 UTC
Next filing
29 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Director Stock Option (Right to Buy) Award $0 +41,200 $0.000000 41,200 11 Nov 2021 Common Stock 41,200 $17.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in three equal annual installments following the date of grant.